Advanced search
Publication Cover
Cancer Investigation Volume 19, 2001 - Issue 2
Submit an article Journal homepage
132
Views
32
CrossRef citations to date
0
Altmetric
Original

Economic Analysis of Amifostine as Adjunctive Support for Patients with Advanced Head and Neck Cancer: Preliminary Results from a Randomized Phase II Clinical Trial from Germany

Charles L. Bennett The Chicago VA Healthcare System/Lakeside Division, the Robert H. Lurie Cancer Center and the Department of Medicine, Northwestern University, Chicago, Illinois, U.S.A.; Lakeside VA Medical Center, 400 East Ontario Street, Suite 205, Chicago, IL, 60611, U.S.A.
, M.D., Ph.D.,
David Lane The Chicago VA Healthcare System/Lakeside Division, the Robert H. Lurie Cancer Center and the Department of Medicine, Northwestern University, Chicago, Illinois, U.S.A.
, B.A.,
Tammy Stinson The Chicago VA Healthcare System/Lakeside Division, the Robert H. Lurie Cancer Center and the Department of Medicine, Northwestern University, Chicago, Illinois, U.S.A.
, M.S.,
Michael Glatzel The Chicago VA Healthcare System/Lakeside Division, the Robert H. Lurie Cancer Center and the Department of Medicine, Northwestern University, Chicago, Illinois, U.S.A.
, M.D. &
Jens Buntzel The Chicago VA Healthcare System/Lakeside Division, the Robert H. Lurie Cancer Center and the Department of Medicine, Northwestern University, Chicago, Illinois, U.S.A.
, M.D.
Pages 107-113 | Published online: 02 Jul 2001

REFERENCES

  • Landis S. H., Murray T., Bolden S., Wingo P. A. Cancer Statistics 1998. Ca: Cancer J. Clini. 1998; 48: 6–30
  • Munro A. An Overview of Randomized Controlled Trials of Adjuvant Chemotherapy in Head and Neck Cancer. Br. J. Cancer 1995; 71: 83–91
  • Brockstein B., Vokes E. E. Chemoradiotherapy for Head and Neck Cancer. PPO Updates 1996; 10: 1–19
  • Vokes E. E., Weichselbaum R. R., Lippman S., Hong W. K. Head and Neck Cancer. N. Engl. J. Med. 1993; 328: 184–194
  • Adelstein D. J., Kalish L. A., Adams G. L., et al. Concurrent Radiation Therapy and Chemotherapy for Locally Advanced Unresectable Squamous Cell Head and Neck Cancer: An Eastern Cooperative Oncology Group Pilot Study. J. Clin. Oncol. 1993; 11: 2136–2142
  • Brockstein B., Haraf D. J., Stenson K., et al. Phase I Study of Concomitant Chemoradiotherapy with Paclitaxel, Fuorouracil, and Hydroxyurea with Granulocyte Colony Stimulating Factor Support for Patients with Poor Prognosis Cancer of the Head and Neck. J. Clin. Oncol. 1998; 16: 735–744
  • Buntzel J., Kuttner K., Schuth J., et al. Selective Cytoprotection with Amifostine in the Treatment of Head and Neck Cancer with Simultaneous Radiochemotherapy. Ann. Oncol. 1998; 9: 505–509
  • Kemp G., Rose P., Lurain J., et al. Amifostine Pretreatment for Protection Against Cyclophosphamide-induced and Cisplatin-induced Toxicities: Results of a Randomized Controlled Trial in Patients with Advanced Ovarian Cancer. J. Clin. Oncol. 1996; 14: 2101–2112
  • McDonald S., Meyerrowitz C., Smudzin T., et al. Preliminary Results of a Pilot Study Using WR-2721 Before Fractionated Irradiation of the Head and Neck to Reduce Salivary Gland Dysfunction. Int. J. Radiat. Oncol. Biol. Phys. 1994; 29: 747–754
  • Tannehill S. P., Mehta M. P. Amifostine and Radiation Therapy: Past, Present, and. Future. Semin. Hematol. 1996; 23S: 69–77
  • Capizzi R. L. Amifostine: The Preclinical Basis for Broad-Spectrum Selective Cytoprotection of Normal Tissues from Cytotoxic Therapies. Semin. Hematol. 1996; 23S: 2–17
  • Bennett C. L., Golub R. M., Calhoun E., et al. Cost-Utility Assessment of Amifostine in First-line Therapy for Ovarian Cancer. Int. J. Gyn. Cancer 1998; 8: 64–72
  • Bohuslaviziki K. H., Klutman S., Brenner W., et al. Salivary Gland Protection by Amifostine in High Dose Radio-Iodine Treatment: Results of a Double-Blind Randomized Controlled Study. J. Clin. Oncol. 1998; 16: 3542–3549
  • Iglehart J. K. Germany's Health Care System. N. Engl. J. Med. 1991; 324: 503–508, and 324, 1750–1756
  • Bennett C. L., George S. L., Vose J. M., et al. Granulocyte Macrophage Colony Stimulating Factor as Adjunct Thereapy in Relapsed Lymphoid Malignancies: Implications for Economic Analyses Alongside Phase III Clinical Trials. Stem Cells 1995; 13: 414–420
  • Bennett C. L., Armitage I. L., Buchner D., Gulati S. Economic Analysis Alongside Phase III Clinical Trials in Cancer. Cancer Invest. 1994; 12: 336–342

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.